Get startedLog in
    Picture of Heron Therapeutics logo

    HRTX — Heron Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Heron Therapeutics Announces Prior Approval Supplement Submission To The FDA For Zynrelef® Vial Access Needle ("Van")

    Picture of Heron Therapeutics logoHeron Therapeutics
    29/05/2024 13:08
    May 29 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES PRIOR APPROVAL SUPPLEMENT
SUBMISSION TO THE FDA FOR ZYNRELEF® VIAL ACCESS NEEDLE ("VAN")
    * HERON ANTICIPATES FDA ACTION ON ZYNRELEF WITHIN 4-6 MONTHS

Source text for Eikon:  ID:nPn1dmFHpa 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Heron Therapeutics

    See all news